After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica, speaker at international seminars on ethics in data sharing

Proud to have Gloria Mason, Director for the Liberia National Ethics Review Board and member of the LiberHetica (http://liberhetica.org) project in the panel of joint online seminars examining the GFBR

Read More

NeuroSolve Project Kick-off Meeting in Lusaka, Zambia

The NeuroSolve consortium held its Project Kick-off Meeting on the 4th December 2023 in Lusaka (Zambia). NeuroSolve is a four-year project funded by EDCTP3, lead by an African-European research consortium

Read More

R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and

Read More